Capillary Electrophoresis Coupled to Mass Spectrometry for Urinary Proteome Analysis

Renal and Urinary Proteomics: Methods and Protocols

Volumn , Issue , 2009, Pages 321-332

  Zürbig, Petra ^a   Schiffer, Eric ^a   Mischak, Harald ^a  

^a MOSAIQUES DIAGNOSTICS GMBH   (Germany)

Author keywords

Biomarkers; Capillary electrophoresis; CE FT ICR; CE migration time; Database; Human urinary proteome

Indexed keywords

EID: 79955780154     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527628612.ch24     Document Type: Chapter

References (55)

1. Iorio, L. and Avagliano, F. (1999) Observations on the Liber medicine orinalibus by Hermogenes. Am J Nephrol, 19, 185-188.
2. Adachi, J., Kumar, C., Zhang, Y., Olsen, J.V., and Mann, M. (2006) The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol, 7, R80.1-R80.16.
3. Celis, J.E., Rasmussen, H.H., Vorum, H., Madsen, P., Honore, B., Wolf, H., and Orntoft, T.F. (1996) Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol, 155, 2105-2112.
4. Delanghe, J. (1997) Use of specific urinary proteins as diagnostic markers for renal disease. Acta Clin Belg, 52, 148-153.
5. Marshall, T. and Williams, K. (1996) Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation. Electrophoresis, 17, 1265-1272.
6. Oh, J., Pyo, J.H., Jo, E.H., Hwang, S.I., Kang, S.C., Jung, J.H., Park, E.K., Kim, S.Y., Choi, J.Y., and Lim, J. (2004) Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics, 4, 3485-3497.
7. Pieper, R., Gatlin, C.L., McGrath, A.M., Makusky, A.J., Mondal, M., Seonarain, M., Field, E., Schatz, C.R., Estock, M.A., Ahmed, N., Anderson, N.G., and Steiner, S. (2004) Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics, 4, 1159-1174.
8. Thongboonkerd, V., McLeish, K.R., Arthur, J.M., and Klein, J.B. (2002) Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int, 62, 1461-1469.
9. Shihabi, Z.K., Konen, J.C., and O'Connor, M.L. (1991) Albuminuria vs urinary total protein for detecting chronic renal disorders. Clin Sci, 37, 621-624.
10. Yudkin, J.S., Forrest, R.D., and Jackson, C.A. (1988) Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet, 2, 530-533.
11. Anderson, N.G., Anderson, N.L., and Tollaksen, S.L. (1979) Proteins of human urine. I. Concentration and analysis by two-dimensional electrophoresis. Clin Chem, 25, 1199-1210.
12. Bueler, M.R., Wiederkehr, F., and Vonderschmitt, D.J. (1995) Electrophoretic, chromatographic and immunological studies of human urinary proteins. Electrophoresis, 16, 124-134.
13. Baer, J.C. and Hjelm, M. (1994) Analysis of urinary proteins by liquid chromatography. Ann Clin Biochem, 31 (Pt 4), 315-326.
14. Jurgens, M., Appel, A., Heine, G., Neitz, S., Menzel, C., Tammen, H., and Zucht, H.D. (2005) Towards characterization of the human urinary peptidome. Comb Chem High Throughput Screen, 8, 757-765.
15. Cadieux, P.A., Beiko, D.T., Watterson, J.D., Burton, J.P., Howard, J.C., Knudsen, B.E., Gan, B.S., McCormick, J.K., Chambers, A.F., Denstedt, J.D., and Reid, G. (2004) Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal, 18, 170-175.
16. Castagna, A., Cecconi, D., Sennels, L., Rappsilber, J., Guerrier, L., Fortis, F., Boschetti, E., Lomas, L., and Righetti, P.G. (2005) Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res, 4, 1917-1930.
17. Edwards, J.J., Anderson, N.G., Tollaksen, S.L., von Eschenbach, A.C., and Guevara, J. Jr (1982) Proteins of human urine. II. Identification by two-dimensional electrophoresis of a new candidate marker for prostatic cancer. Clin Chem, 28, 160-163.
18. Grover, P.K. and Resnick, M.I. (1997) High resolution two-dimensional electrophoretic analysis of urinary proteins of patients with prostatic cancer. Electrophoresis, 18, 814-818.
19. Rehman, I., Azzouzi, A.R., Catto, J.W., Allen, S., Cross, S.S., Feeley, K., Meuth, M., and Hamdy, F.C. (2004) Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study. Urology, 64, 1238-1243.
20. Irmak, S., Tilki, D., Heukeshoven, J., Oliveira-Ferrer, L., Friedrich, M., Huland, H., and Ergun, S. (2005) Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics, 5, 4296-4304.
21. Rasmussen, H.H., Orntoft, T.F., Wolf, H., and Celis, J.E. (1996) Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol, 155, 2113-2119.
22. Saito, M., Kimoto, M., Araki, T., Shimada, Y., Fujii, R., Oofusa, K., Hide, M., Usui, T., and Yoshizato, K. (2005) Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers. Eur Urol, 48, 865-871.
23. Sharma, K., Lee, S., Han, S., Lee, S., Francos, B., McCue, P., Wassell, R., Shaw, M.A., and RamachandraRao, S.P. (2005) Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics, 5, 2648-2655.
24. Thongboonkerd, V., Barati, M.T., McLeish, K.R., Benarafa, C., Remold-O'Donnell, E., Zheng, S., Rovin, B.H., Pierce, W.M., Epstein, P.N., and Klein, J.B. (2004) Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol, 15, 650-662.
25. Fliser, D., Wittke, S., and Mischak, H. (2005) Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes. Electrophoresis, 26, 2708-2716.
26. Haubitz, M., Wittke, S., Weissinger, E.M., Walden, M., Rupprecht, H.D., Floege, J., Haller, H., and Mischak, H. (2005) Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int, 67, 2313-2320.
27. Neuhoff, N., Kaiser, T., Wittke, S., Krebs, R., Pitt, A., Burchard, A., Sundmacher, A., Schlegelberger, B., Kolch, W., and Mischak, H. (2004) Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. Rapid Commun Mass Spectrom, 18, 149-156.
28. Weissinger, E.M., Wittke, S., Kaiser, T., Haller, H., Bartel, S., Krebs, R., Golovko, I., Rupprecht, H.D., Haubitz, M., Hecker, H., Mischak, H., and Fliser, D. (2004) Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int, 65, 2426-2434.
29. Kaiser, T., Kamal, H., Rank, A., Kolb, H.J., Holler, E., Ganser, A., Hertenstein, B., Mischak, H., and Weissinger, E.M. (2004) Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood, 104, 340-349.
30. Wittke, S., Haubitz, M., Walden, M., Rohde, F., Schwarz, A., Mengel, M., Mischak, H., Haller, H., and Gwinner, W. (2005) Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant, 5, 2479-2488.
31. Schaub, S., Rush, D., Wilkins, J., Gibson, I.W., Weiler, T., Sangster, K., Nicolle, L., Karpinski, M., Jeffery, J., and Nickerson, P. (2004) Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol, 15, 219-227.
32. Schaub, S., Wilkins, J.A., Antonovici, M., Krokhin, O., Weiler, T., Rush, D., and Nickerson, P. (2005) Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant, 5, 729-738.
33. Harrison, H.H. (1991) The ''ladder light chain'' or ''pseudo-oligoclonal'' pattern in urinary immunofixation electrophoresis (IFE) studies: a distinctive IFE pattern and an explanatory hypothesis relating it to free polyclonal light chains. Clin Chem, 37, 1559-1564.
34. Tichy, M., Stulik, J., Kovarova, H., Mateja, F., and Urban, P. (1995) Analysis of monoclonal immunoglobulin light chains in urine using two-dimensional electrophoresis. Neoplasma, 42, 31-34.
35. Myrick, J.E., Caudill, S.P., Robinson, M.K., and Hubert, I.L. (1993) Quantitative two-dimensional electrophoretic detection of possible urinary protein biomarkers of occupational exposure to cadmium. Appl Theor Electrophor, 3, 137-146.
36. Mischak, H., Apweiler, R., Banks, R.E., Conaway, M., Coon, J.J., Dominizak, A., Ehrich, J.H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D.F., Jankowski, V., Julian, B.A., Kolch, W., Massy, Z., Neususs, C., Novak, J., Peter, K., Rossing, K., Schanstra, J.P., Semmes, O.J., Theodorescu, D., Thongboonkerd, V., Weissinger, E.M., Van Eyk, J.E., and Yamamoto, T. (2007) Clinical Proteomics: a need to define the field and to begin to set adequate standards. PROTEOMICS Clin Appl, 1, 148-156.
37. Schaub, S., Wilkins, J., Weiler, T., Sangster, K., Rush, D., and Nickerson, P. (2004) Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int, 65, 323-332.
38. Theodorescu, D., Wittke, S., Ross, M.M., Walden, M., Conaway, M., Just, I., Mischak, H., and Frierson, H.F. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol, 7, 230-240.
39. Kolch, W., Neususs, C., Pelzing, M., and Mischak, H. (2005) Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev, 24, 959-977.
40. Theodorescu, D., Fliser, D., Wittke, S., Mischak, H., Krebs, R., Walden, M., Ross, M., Eltze, E., Bettendorf, O., Wulfing, C., and Semjonow, A. (2005) Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis, 26, 2797-2808.
41. Zurbig, P., Renfrow, M.B., Schiffer, E., Novak, J., Walden, M., Wittke, S., Just, I., Pelzing, M., Neususs, C., Theodorescu, D., Root, K.E., Ross, M.M., and Mischak, H. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis, 27, 2111-2125.
42. Pisitkun, T., Johnstone, R., and Knepper, M.A. (2006) Discovery of urinary biomarkers. Mol Cell Proteomics, 5, 1760-1771.
43. Villanueva, J., Shaffer, D.R., Philip, J., Chaparro, C.A., Erdjument-Bromage, H., Olshen, A.B., Fleisher, M., Lilja, H., Brogi, E., Boyd, J., Sanchez-Carbayo, M., Holland, E.C., Cordon-Cardo, C., Scher, H.I., and Tempst, P. (2006) Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest, 116, 271-284.
44. Geiger, T. and Clarke, S. (1987) Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. J Biol Chem, 262, 785-794.
45. Stephenson, R.C. and Clarke, S. (1989) Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins. J Biol Chem, 264, 6164-6170.
46. Mischak, H., Kaiser, T., Walden, M., Hillmann, M., Wittke, S., Herrmann, A., Knueppel, S., Haller, H., and Fliser, D. (2004) Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond), 107, 485-495.
47. Rossing, K., Mischak, H., Parving, H.H., Christensen, P.K., Walden, M., Hillmann, M., and Kaiser, T. (2005) Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int, 68, 193-205.
48. Sniehotta, M., Schiffer, E., Zurbig, P., Novak, J., and Mischak, H. (2007) CE-a multifunctional application for clinical diagnosis. Electrophoresis, 28, 1407-1417.
49. Wittke, S., Mischak, H., Walden, M., Kolch, W., Radler, T., and Wiedemann, K. (2005) Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis, 26, 1476-1487.
50. Decramer, S., Wittke, S., Mischak, H., Zurbig, P., Walden, M., Bouissou, F., Bascands, J.L., and Schanstra, J.P. (2006) Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med, 12, 398-400.
51. Weissinger, E.M., Mischak, H., Ganser, A., and Hertenstein, B. (2006) Value of proteomics applied to the follow-up in stem cell transplantation. Ann Hematol, 85, 205-211.
52. Weissinger, E.M., Schiffer, E., Hertenstein, B., Ferrara, J.L., Holler, E., Stadler, M., Kolb, H.J., Zander, A., Zurbig, P., Kellmann, M., and Ganser, A. (2007) Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood, 109, 5511-5519.
53. Fliser, D., Novak, J., Thongboonkerd, V., Argiles, A., Jankowski, V., Girolami, M.A., Jankowski, J., and Mischak, H. (2007) Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol, 18, 1057-1071.
54. von zur Mühlen, C., Schiffer, E., Zürbig, P., Kellmann, M., Brasse, M., Meert, N., Vanholder, R.C., Dominiczak, A.F., Chen, Y.C., Mischak, H., Bode, C., and Peter, K.H. (2009) Evaluation of urine proteome pattern analysis for its potential to reflect coronary artery atherosclerosis in symptomatic patients. J Proteosome Res, 6 (1), 335-345.
55. Zimmerli, L.U., Schiffer, E., Kellmann, M., Zürbig, P., Good, D.M, Mouls, L., Pitt, A.R., Coon, J.J., Schmieder, R.E., Peter, K.H., Mischak, H., Kolch, W., Delles, C., and Dominiczak, A.F. (2008) Urinary proteomic biomarkers in coronary artery disease, Mol Cell Proteomics, 7 (2), 290-298.